Polycythemia vera and essential thrombocythemia of intermediate-age: A real-life, multicenter analysis of first-line treatment approach
of thromboembolic complications with respect to ET.19 Additionally, a recent publication showed that the cumulation of CV risk factors in PV patients, independent of age, has a negative impact on OS.20 Treatment recommendations underline that all patients with PV, regardless of age, should receive phlebotomy
of thromboembolic complications with respect to ET.19 Additionally, a recent publication showed that the cumulation of CV risk factors in PV patients, independent of age, has a negative impact on OS.20 Treatment recommendations underline that all patients with PV, regardless of age, should receive phlebotomy